Diseases of the Cardiovascular System | Genetics - Pediatric

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD (ASCENT ASD)

Volunteers
Health Professionals

What is the purpose of this trial?

Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect.

Trial with
CARAG, LLC
Ages
84 years and younger
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Amanda Catucci

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Jeremy Asnes, MD
Associate Professor of Pediatrics (Cardiology); Section Chief, Pediatric Cardiology; Director, Congenital Cardiac Catheterization Laboratory

Sub-Investigator

Britton Keeshan, MD, MPH

Last Updated
04/21/2023
Study HIC
#2000029209